Art’s Way director granted 1,000 stock shares
A non-cash director compensation grant increased Thomas E. Buffamante’s directly held ARTW shares to 65,000.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ARTS WAY MANUFACTURING CO INC (symbol: ARTW) is the issuer of record for a Form 4 filing submitted to the SEC. Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.
ARTS WAY MANUFACTURING CO INC (ARTW) reported that director Thomas E. Buffamante received an award of 1,000 shares of Common Stock on August 31, 2026. The shares are fully-vested restricted stock granted under a director compensation plan, and his directly held stake increased to 65,000 shares. No Rule 10b5-1 trading plan is reported for this award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 1,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.
Key Figures
Key Terms
restricted stock financial
fully-vested financial
director compensation plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ARTW director Thomas E. Buffamante report on this Form 4 for ARTS WAY MANUFACTURING CO INC (ARTW)?
Was the ARTW Form 4 transaction a market purchase or sale?
Was the ARTW Form 4 transaction made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.